North Korea Also Refused U.S.-Made 'Novavax' Vaccine

[Image source=Yonhap News]

[Asia Economy Reporter Lee Ji-eun] It has been revealed that the supply of U.S.-made Novavax COVID-19 vaccines allocated to North Korea was canceled.

Radio Free Asia (RFA) reported on the 22nd that the international vaccine supply project 'COVAX Facility' recently canceled 252,000 doses of Novavax's COVID-19 vaccine 'Covovax' allocated to North Korea.

According to UNICEF statistics as of the previous day, the current vaccine allocation by COVAX to North Korea is counted as 1,288,800 doses, excluding the Covovax doses from the original 1,540,800 doses. The reason for the cancellation of the Covovax vaccine allocation is unknown, but it is presumed that North Korea did not express willingness to accept it.

Initially, it was known that North Korea wanted U.S.-made vaccines, drawing attention to North Korea's acceptance of the Covovax vaccine. A Ministry of Unification official told reporters on the same day, "It is understood that various working-level consultations between COVAX and North Korea for vaccine support are still ongoing."

This content was produced with the assistance of AI translation services.